Safety Study of XL844 in Subjects With Chronic Lymphocytic Leukemia

Summary

The purpose of this study is to assess the safety and tolerability of different doses of XL844 when given orally to adults with recurrent or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Timeline

Start

—

Primary completion

—

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “Study closed due to slow enrollment”

Drugs

Indications